
Has a portfolio of biosimilar products. Please contact us for a complete list or for the development of a product that you would like to commercialize.
Under development are pegylated biosimilars and monoclonal antibodies.
Seeking marketing partners for: Europe, USA, Japan, and other markets.
Mr. Thomas L. Flynn III
Chief Executive Officer